Evidence map›Paper›PMID 36933678›Full record

ArticleThe Journal of arthroplasty2023

Frank Stinchfield Award: Creation of a Patient-Specific Total Hip Arthroplasty Periprosthetic Fracture Risk Calculator.

Cody C Wyles, Hilal Maradit-Kremers, Kristin M Fruth, Dirk R Larson, Bardia Khosravi, Pouria Rouzrokh, Quinn J Johnson, Daniel J Berry, Rafael J Sierra, Michael J Taunton and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of arthroplasty, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Ancient Principles, Modern Impact: Increased Femoral Offset Demonstrates Decreased Load to Failure in Total Hip Arthroplasty.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2025
    Article
  4. Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Cody C WylesMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Hilal Maradit-KremersMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota; Mayo Clinic Department of Quantitative Health Sciences, Rochester, Minnesota.
Kristin M FruthMayo Clinic Department of Quantitative Health Sciences, Rochester, Minnesota.
Dirk R LarsonMayo Clinic Department of Quantitative Health Sciences, Rochester, Minnesota.
Bardia KhosraviMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Pouria RouzrokhMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Quinn J JohnsonMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Daniel J BerryMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Rafael J SierraMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Michael J TauntonMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Matthew P AbdelMayo Clinic Department of Orthopedic Surgery, Rochester, Minnesota.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

Resource CoreP30AR076312 · NIAMS · MAYO CLINIC ROCHESTER · PI Daniel Berry · 2019 to 2026
$5.5M
Precision Orthopedics: Multimodal Data Infrastructure for Personalized Surgical Decisions in Joint ArthroplastyR01AR073147 · NIAMS · MAYO CLINIC ROCHESTER · PI Hilal Maradit Kremers · 2018 to 2026
$3.5M
Cardiotoxicity in Total Joint ArthroplastyR01HL147155 · NHLBI · MAYO CLINIC ROCHESTER · PI MARADIT KREMERS, HILAL · 2019 to 2022
$2.8M
NHLBI NIH HHS R01 HL147155NIAMS NIH HHS P30 AR076312NIAMS NIH HHS R01 AR073147
6 · The paper itself

Abstract

backgroundMany risk factors have been described for periprosthetic femur fracture (PPFFx) following total hip arthroplasty (THA), yet a patient-specific risk assessment tool remains elusive. The purpose of this study was to develop a high-dimensional, patient-specific risk-stratification nomogram that allows dynamic risk modification based on operative decisions.

methodsWe evaluated 16,696 primary nononcologic THAs performed between 1998 and 2018. During a mean 6-year follow-up, 558 patients (3.3%) sustained a PPFFx. Patients were characterized by individual natural language processing-assisted chart review on nonmodifiable factors (demographics, THA indication, and comorbidities), and modifiable operative decisions (femoral fixation [cemented/uncemented], surgical approach [direct anterior, lateral, and posterior], and implant type [collared/collarless]). Multivariable Cox regression models and nomograms were developed with PPFFx as a binary outcome at 90 days, 1 year, and 5 years, postoperatively.

resultsPatient-specific PPFFx risk based on comorbid profile was wide-ranging from 0.4-18% at 90 days, 0.4%-20% at 1 year, and 0.5%-25% at 5 years. Among 18 evaluated patient factors, 7 were retained in multivariable analyses. The 4 significant nonmodifiable factors included the following: women (hazard ratio (HR) = 1.6), older age (HR = 1.2 per 10 years), diagnosis of osteoporosis or use of osteoporosis medications (HR = 1.7), and indication for surgery other than osteoarthritis (HR = 2.2 for fracture, HR = 1.8 for inflammatory arthritis, HR = 1.7 for osteonecrosis). The 3 modifiable surgical factors were included as follows: uncemented femoral fixation (HR = 2.5), collarless femoral implants (HR = 1.3), and surgical approach other than direct anterior (lateral HR = 2.9, posterior HR = 1.9).

conclusionThis patient-specific PPFFx risk calculator demonstrated a wide-ranging risk based on comorbid profile and enables surgeons to quantify risk mitigation based on operative decisions. LEVEL OF EVIDENCE: Level III, Prognostic.

Indexed as

Arthroplasty, Replacement, HipAwards and PrizesFemoral FracturesHip ProsthesisPeriprosthetic FracturesFemaleHumansReoperationRetrospective StudiesRisk Factorspatient-specificperiprosthetic femur fractureprognosisrisk calculatorrisk modificationtotal hip arthroplasty

Identifiers

PMID36933678
PMCPMC10272077
OpenAlexW4327559505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.